Address:
East Carolina University Brody School of Medicine
600 Moye Boulevard
Greenville, NC 27834
Office: 252-744-5418
Fax: 252-744-5777
Email: Zervose@ecu.edu
Pending Appointment:
July 2007
Professor and Chief
Division of Surgical Oncology
East Carolina University, Brody School of Medicine
Associate Director, Leo W. Jenkins Cancer Center
Current Appointment:
July 2006- present:
Associate Professor of Surgery with tenure, Department of Surgery, Division of General Surgery, University of South Florida
July 2001 – June 2006:
Assistant Professor of Surgery, Division of General Surgery
Department of Surgery, University of South Florida
July 2001 – present
Associate Professor
Department of Clinical Investigation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
Education:
September 1984- May 1988: Bachelor of Arts - Economics, With Highest Distinction: University of Michigan College of Literature, Arts and Sciences, Ann Arbor, MI
August 1988 – May 1992: Doctor of Medicine: University of Michigan College of Medicine, Ann Arbor, MI
Professional Training:
July 1992- June 1993: Internship – General Surgery: University of Michigan Hospitals, Ann Arbor, MI
July 1993- June 1995: Junior Surgical Resident – General Surgery: University of South Florida Hospitals, Tampa, FL
July 1995- June 1997: Fellowship in Surgical Research - University of South Florida, Tampa, FL
July 1997- June 1998: Senior Surgical Resident - University of South Florida, Tampa, FL
July 1998- June 1999: Chief Resident in Surgery - University of South Florida, Tampa, FL
July 1999- June 2000: Clinical Surgical Oncology Fellow - Ohio State University, Columbus, OH
July 2000- June 2001: Surgical Oncology Research Fellow - Division of Human Medical Genetics – laboratory of Albert delaChapelle, PhD, Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, OH
Board Certification:
1993 National Board of Medical Examiners
1999 American Board of Surgery
Editorial Review:
Editorial Board:
Surgical Rounds
Refereee:
Journal of Surgical Research – 2003
British Journal of Cancer - 2005
Journal of Oncology – 2002
Frontiers in Bioscience – 2005
Digestive Diseases and Science – 2005
Journal of Surgical Oncology – 2005
Archives of Surgery -2006
Expert Opinion on Biological Therapy -2007
Journal of the American College of Surgeons - 2007
Associations:
American College of Surgeons, Fellow (ACS), 2001
International Hepatobiliary Association, (IHPBA), 2003
Association for Academic Surgery (AAS), 2003
Frederick A. Coller Surgical Society, 2000
Society of Surgical Oncology, 2003
Tampa Bay Surgical Society, 2001
Florida Surgical Society, 2001
American Association for Cancer Research, 2000
American Society of Clinical Oncology, 2000 Florida Chapter of the American College of Surgeons, 2001
Applications in process:
Society of University Surgeons 2008 (application submitted)
Southern Surgical Association
Licensure:
State of Ohio
State of Florida
Achievement and Honors:
1984 Winner, The Grand Rapids Press Wonderland Writer’s
Competition
1984 Grand Rapids Ottawa Hills High School, Valedictorian
1984 Regents Alumni Scholarship, University of Michigan
1984 Merit Scholarship, University of Michigan
1984 Foster Foundation Scholarship, Grand Rapids, MI
1984 Winchester Foundation Scholarship, Grand Rapids, MI
1984 American Hellenic Educational Progressive Association
Scholarship
1984 Pancretan Association of America Scholarship
1988 B.A.University of Michigan College of Literature Science and
Arts, “With Highest Distinction”
1994 H. Quillian Jones Award, Best Resident Paper, Florida Committee
on Trauma
1995 1st Place, Resident Research Competition, Florida Surgical Society
1995 SSAT / Ross Resident Research Award
1996 Florida Committee on Trauma, Resident Paper Competition
Award, 1st Place
1996 1st Place, Resident Research Competition, Florida Surgical Society
1997 1st Place, Physician’s in Training Paper Competition Southern Medical Association
1997 Watson Clinic Award - Best Research Presentation USF Research
Day
1998 Frederick A. Coller Surgical Society, Coller Society Clinical
Tour
1998 Elected to Alpha Omega Alpha Medical Honor Society
1999 Society of Abdominal Surgeons Resident Research Award
2000 Successful completion of American Board of Surgery Qualifying
Exam
2001 Scholarship Recipient American Association for Cancer Research
Molecular Biology in Clinical Oncology, Aspen, CO July 2000
2002 Scholarship Recipient American Association of Clinical Oncology (ASCO)
–Methods in Clinical Cancer Research , Vail, CO
2001 Columbus Surgical Society: 1st Place Resident Paper Competition
2001 American Society of Breast Surgeons: Best Poster Presentation, La
Jolla, CA May 2001
2001 Ohio State University: 1st Place – Resident Paper Competition –
Mentor
2003 Association of VA Surgeons Best Scientific Presentation
2004 USF Research Day – Best Scientific Poster
2006 Bronze Medal Award Winner – Dean’s Leadership Council - University of South Florida
2007 Best Post-Graduate Research Presentation – USF Research Day 2007
Primary Mentorship:
Academic:
Sarah Cowgill, M.D. Masters Student in Clinical Research, University of South Florida K30 Master’s Program; Director: Ken Zuckerman, M.D.
Laboratory:
Nasreen A. Vohra, M.D., 2 years in Lab
Surgical Research Fellow, USF
Previous laboratory fellows:
Dana Osborne, M.D.,2004-2006
General Surgery Resident USF
Application to surgical oncology
Fellowships in process
Brian A. Boe, MS, 2004-2005
Medical Student Level II USF
Alan J. Durkin, M.D., 2002-2004
Plastic Surgery Fellow - USF
Mark Bloomston, M.D., 2000-2002
Asistant Professor of Surgery,
The Ohio State University,
Division of Surgical Oncology
Publications (hyperlinks to free online reprints in blue):
1. Zervos, E. “War”, Wonderland Magazine, The Grand Rapids Press, June 3, 1984, pp. 9-10.
2. Zervos, EE, Bass, SS, Robson MC, Rosemurgy, AS. Fluconazole increases the bactericidal
activity of neutrophils. J Trauma 41:10-14, 1996.
3. Zervos, EE, Fink, GW, Norman, JG, Robson, MC, Rosemurgy, AS. Fluconazole increases the bactericidal activity of neutrophils through non-cytokine mediated pathway.
J Trauma, 41: 465-70, 1996.
4. Camps, MA, Zervos, EE, Goode, SE, Rosemurgy, AS. Does inadequate weight loss following bariatric surgery predict staple line failure? A prospective study. Obesity Surgery, 6:330-5, 1996.
5. Camps, MA, Zervos, EE, Goode, SE, Rosemurgy, AS. Impact of bariatric surgery on body image perception and sexuality in morbidly obese patients and their partners. Obesity Surgery, 6:356-60,1996.
6. Rosemurgy, AS, Zervos, EE. Sweeney, JF, Djieu, JY. Candida antigen titer dilution and death after injury. Br J Surg, 84:771-774, 1997.
7. Zervos, EE, McCormick, J, Goode, SE, Rosemurgy, AS. Peritoneovenous shunts in patients with intractable ascites: palliation at what price? Am. Surg, 63:157-62, 1997.
8. Rosemurgy, AS, Zervos, EE, Goode, SE, Black, TJ, Zwiebel, BR. Differential effects on portal and effective hepatic blood flow: a comparison between TIPS and small diameter H-graft portacaval shunt. Ann Surg, 225:601-8, 1997.
9. Zervos EE, Rosemurgy AS. Small-diameter portocaval shunt vs. transjugular intrahepatic portosystemic shunt for portal hypertension.
Adv Surg. 1997;31:105-25.
10. Zervos, EE, Norman, JG, Gower, WR, Franz, MG, Rosemurgy, AS. Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo. J Surg Res, 69: 367-371, 1997.
11. Zervos, EE, Norman, JG, Salhab, C, Rosemurgy, AS. Sublethal Hemorrhage Blunts the
Inflammatory Cytokine Response to Endotoxin in a Rat Model. J Trauma, 46: 145-149, 1999
12. Zervos, EE, Norman, JG, Carey, LC, Salhab, C, Rosemurgy, AS. Conditioning to hemorrhagic shock improves survival and attenuates inflammatory cytokine gene induction in the lung, liver and spleen of rats. Surg Forum, 48: 127-129, 1997.
13. Rosemurgy, AS, Bloomston, PM, Zervos, EE, Goode, SE, Pencev, D, Zweibel, BR, Black, TJ. TIPS vs. H-graft portacaval shunt in the management of bleeding varices: a cost benefit analysis. Surgery, 122:794-799, 1997.
14. Zervos, EE, Norman, JG, Carey, LC, Rosemurgy, AS. Cytokine activation through sublethal hemorrhage is protective against early, lethal endotoxic challenge. Arch Surg 132: 1216-1221, 1997.
15. Bloomston, PM, Zervos, EE, Goode, SE, Rosemurgy, AS. Outcomes following bariatric surgery In super vs. Morbidly obese patients: Does weight matter? Obesity Surg, 7: 414-419, 1997.
16. Bloomston, PM, Zervos, EE, Powers, P, Rosemurgy, AS. Vertical banded gastroplasty in a
patient with multiple personalities: nuances and complexities of care. Obesity Surg, 7:363-366, 1997.
17. Zervos, EE, Goode SE, Rosemurgy, AS. Immediate and long term portal hemodynamic
consequences of the small diameter H-graft portacaval shunt. J Surg Res, 74: 71-75, 1998.
18. Zervos, EE, Goode SE, Rosemurgy, AS. Small diameter H-graft portacaval shunt reduces portal pressure without compromising effective hepatic blood flow. Amer Surg, 64:71-76, 1998.
19. Denham, EW, Yang, JG, Fink, G, Zervos, EE, Norman, JG. Pancreatic ascites as a powerful inducer of inflammatory cytokines: the role of known vs unknown factors. Arch Surg, 132: 1231- 1236, 1997.
20. Rosemurgy, AS, Serafini, FS, Zervos, EE, Goode, SE. Small Diameter H-graft portacaval shunt: excellent outcomes in more than 100 patients. J Gastrointestinal Surg, 2 (6): 585-591, 1998.
21. Rosemurgy AS, Bloomston M, Zervos EE, Goode SE, Pencev D, Zweibel B, Black TJ. Transjugular Intrahepatic Portosystemic Shunt versus H-Graft Portacaval Shunt in the Management of Bleeding Varices: A Cost-Benefit Analysis. Curr Surg 1998; 55: 171-2.
22. Bloomston, M, Zervos, EE, Gonzalez, R, Albrink, M, Rosemurgy, AS. Quality of life and
antireflux medication use following laparoscopic Nissen fundoplication. Amer Surg, 64: 509-514, 1998.
23. Denham, D, Franz, MG, Zervos, EE, Gower W, Rosemurgy, AS, Norman JG. Directed antisense therapy confirms the role of PKC- in the tumorigenicity of pancreatic cancer. Surgery 124: 218-224, 1998.
24. Zervos, EE, Shafii, AE, Rosemurgy, AS. Matrix metalloproteinase inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer. J Surg Res, 81:65-68, 1999.
25. Zervos, EE, Shafii, AE, Haq, M, Rosemurgy, AS. Matrix metalloproteinase inhibition supresses MMP-2 activity and activation of PANC-1 cells in vitro. J Surg Res, 84:162-167, 1999.
26. Zervos, EE, Franz, M, Shafii, AE, Salhab, K, Rosemurgy, AS. Matrix metalloproteinase inhibition improves survival in an orthotopic model of human pancreatic cancer. J Gastrointestinal Surgery, 4:614-619, 2000.
27. Haq, M, Shafii, A, Zervos, EE, Rosemurgy, AS. Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer. Cancer Research, 60: 3207-3211; 2000.
28. Zervos, EE, Rosemurgy, AS. Management of Medically Refractory Ascites. Abdominal Surgery, Fall 1999, pp 2-8.
29. Zervos, EE, Saha, S, Hoshaw-Woodard, S, Wheatley, G, Burak, W. Localizing the sentinel node outside of the specialty center: success of the lymphatic mapping course in disseminating new technology. Ann Surg Onc. 8:7-12; 2001.
30. Zervos, EE, Rosemurgy, AS. Management of Medically Refractory Ascites: A Surgeon’s Guide. (review) Am J Surgery 2001; 181: 256-264.
31. Zervos, EE, Burak, WE. Lymphatic Mapping for Breast Cancer: Experience at The Ohio State University. Breast Cancer 7:195-200; 2000.
32. Desai, D, Zervos, EE, Martin, EW. Positron Emission Tomography Affects Surgical Management in Recurrent Colorectal Cancer Patients. Ann Surg Onc 2003; 10(1):59-64.
33. Serafini FM, Bloomston, MP, Zervos, EE, et al. Laparoscopic Revision of Failed Anti-Reflux Operations. J Surg Res 2001; 95:13-18.
34. Zervos EE, Desai DC, DePalatis LR, Soble D, Martin EW. FDG-Pet Guided Surgery for Recurrent Colorectal Cancer: A Feasibility Study. J Surg. Res 2001; 97:9-13.
35. Burak WE, Holleneck ST, Zervos EE, et al. Physiologic and socioeconomic consequences of breast cancer surgery: a comparison between sentinel lymph node biopsy and axillary lymph node dissection. American Journal of Surgery 2002; 182:316-320.
36. Zervos EE, Badgwell B, Burak WB, Arnold MW, Martin EW. FDG-PET as an adjunct to CEA in the management of colorectal cancer patients with rising CEA and non-diagnostic radiologic workup. Surgery 2001; 130:636-644.
37. Zervos EE, Badgwell BD, Abdessalam SF, Farrar WB, Walker MJ, Yee LD, Burak WE Jr. Selective sentinel lymph node analysis in breast cancer. Am J Surg. 2001 Oct;182(4):372-6.
38. Abdessalam SF, Zervos EE, Prasad M, Farrar WB, Yee LD, Walker MJ, Carson WB, Burak WB. Predictors of positive axillary lymph nodes following sentinel lymph node biopsy in breast cancer. Am J Surg. 2001 Oct;182(4):316-20.
39. Nakagawa H, Nuovo GJ, Zervos E, Martin EW, Salovaara Reijo, Aaltonen LA, delaChapelle A. Age related hypermethylation of MLH1 5’ region in normal colonic mucosa is associated with microsatellite- unstable colorectal cancer development. Cancer Research 61:6991-6995, 2001.
40. Zervos EE, Burak WB, Jr. Lymphatic Mapping in Solid Neoplasms: State of the Art. Cancer Control 2002 May-Jun;9(3):189-202. Review
41. Rosemurgy AS, Bloomston M, Zervos EE, Goode SE, Pencev D, Zweibel B, Black TJ. Transjugular Intrahepatic Portosystemic Shunt versus H-Graft Portacaval Shunt in the Management of Bleeding Varices: A Cost-Benefit Analysis. Curr Surg 1998; 55: 171-2.
42. Bloomston M, Shafii AS, Zervos E, Rosemurgy AS. Timp-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis. J Surg Res. 2002 Jan; 102(1):39-44.
43. Bloomston M, Shafii A, Zervos E, Rojiani A, Rosemurgy AS.MMP-2 and TIMP-1 are derived from, not in response to, pancreatic cancer. J Surg Res. 2002 Jan; 102(1):35-8.
44. Haq M, Shafii A, Zervos E, Rosemurgy AS. In vitro and in vivo matrix metalloproteinase production by pancreatic cancer cells and by distant organs. Int J Surg Investig. 2000;1(6):459-65.
45. Burak WB, Hollenbeck S, Zervos E, Yee LD, Young D. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg. 2002 Jan; 183(1):23-7.
46. Bloomston, MB, Zervos, EE, Rosemurgy, AS. Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials. Ann Surg Oncol. 2002 Aug-Sep;9(7):668-74.
47. Desai, D, Zervos, EE, Arnold, M.W., Burak, W, Mantil, J, Martin, EW. Positron emission tomography affects surgical management in recurrent colorectal cancer patients.
Ann Surg Oncol. 2003 Jan-Feb;10(1):59-64.
48. Bloomston M, Binitie O, Fraiji E, Murr M, Zervos E, Goldin S, Kudryk B, Zwiebel B, Black T, Fargher S, Rosemurgy AS. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am Surg 2002 Sep;68(9):827-31
49. Bloomston M, Durkin A, Yang I, Enkeman S, Rojiani M, Yeatman T, Rosemurgy AS and Zervos EE. Identification of Molecular Markers for Pancreatic Neuroendocrine Tumors by Genetic Profiling of Core Biopsies. Ann Surg Oncol. 2004 Apr;11(4):413-9.
50. Zervos EE, Rosemurgy AS, Al-Saif O, Durkin AJ.Surgical Management of Early Stage Pancreatic Carcinoma. Cancer Control, January/February 2004; 11:23-31.
51. Durkin AJ, Bloomston PM, Giarelli N, Yeatman TJ, Rosemurgy AS, Zervos EE. Differential expression of the tie-2 receptor and its ligands in pancreatic carcinoma. Surgical Forum Volume LIV, 2003.
52. Rosemurgy AS, Zervos EE. Management of variceal hemorrhage. Curr Probl Surg. 2003 Jun;40(6):263-343. Review.
53. Durkin AJ, Bloomston M, Yeatman TJ, Gilbert-Barness E, Cojita D, Rosemurgy AS, Zervos EE. Differential expression of the Tie-2 receptor and its ligands in human pancreatic tumors. J Am Coll Surg. 2004 Nov;199(5):724-31.
54. Badgwell BD, Povoski SP, Abdessalam SF, Young DC, Farrar WB, Walker MJ, Yee LD,
Zervos EE, Carson WE 3rd, Burak WE Jr. Patterns of recurrence after sentinel lymph node biopsy for breast cancer. Ann Surg Oncol. 2003 May-Jun;10(4):376-80.
55. Durkin AJ, Bloomston PM, Rosemurgy AS, Giarelli N, Cojita D, Yeatman TJ, Zervos EE. Defining the role of the epidermal growth factor receptor in pancreatic cancer grown in vitro. Am J Surg. 2003 Nov;186(5):431-6.
56. Fraiji E Jr, Bloomston M, Carey L, Zervos E, Goldin S, Banasiak M, Wallace M, Rosemurgy AS. Laparoscopic management of symptomatic achalasia associated with epiphrenic diverticulum. Surg Endosc. 2003 Oct; 17(10):1600-3. Epub 2003 Jul 21.
57. Rosemurgy AS, Zervos EE, Bloomston M, Durkin AJ, Clark WC, Goff S. Post-shunt resource consumption favors small-diameter prosthetic H-graft portacaval shunt over TIPS for patients Ann Surg. 2003 Jun;237(6):820-5; discussion 825-7.
58. Zervos EE, Durkin AJ. Differential gene expression of the Tie-2 receptor and its ligands in human pancreatic tumors. J Am Coll Sur 2004; 199:724-731.
59. Durkin AJ, Korkolis D, Al-Saif O, Zervos EE. Full-term gestation and transvaginal delivery after wide resection of an abdominal desmoid tumor during pregnancy. J Surg Oncol. 2005 Feb 1;89(2):86-90.
60. Zervos EE, Pearson H, Durkin AJ, Thometz D, Rosemurgy P, Kelley S, Rosemurgy AS. In-Continuity Hepatic Resection for Advanced Hilar Cholangiocarcinoma: Survival and Complications. Am J Surg 2004; 188: 584-588.
61. Rosemurgy AS, Zervos EE, Clark WC, Thometz DP, Black TJ, Zwiebel BR, Kudryk BT, Grundy LS, Carey LC.TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial. Ann Surg. 2004 Jun;239(6):883-9; discussion 889-91.
62. Rosemurgy AS, Thometz DP, Zervos EE. Portal blood flow, effective hepatic blood flow, and outcome after partial portal decompression. J Surg Res. 2004 Mar;117(1):64-70.
63. Kelley ST, Bloomston M, Serafini F, Carey LC, Karl RC, Zervos E, Goldin S, Rosemurgy P, Rosemurgy AS. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy. Am Surg. 2004 Sep;70(9):743-8; discussion 748-9.
64. Osborne, D, Boe B, Rosemurgy AS, Zervos EE. 20mm laparoscopic cholecystectomy: fewer ports results in less pain, shorter hospitalization and faster return to normal activity. Am Surg 2005; 71: 298-302.
65. Keeling, WB, Osborne D, Luckey, N, Rakita, S. Zervos, EE. Bleeding gastric varices and a mesenteric fibroma in a gravida patient. Surgical Rounds 29(2); 2006:
66. Zervos, EE, Osborne, D, Boe, B. Luzardo, G, Rosemurgy, AS. Prognostic Significance of New Onset Ascites in Patients with Pancreatic Cancer. W. J Surg Onc. 2006 Mar 28;4:16.
67. Zervos EE, Osborne D, Goldin SB, Villadolid DV, Thometz DP, Durkin A, Carey LC, Rosemurgy AS. Staging systems do not accurately predict survival in hilar cholangiocarcinoma: promoting an aggressive operative approach. American Journal of Surgery, Am J Surg. 2005 Nov;190(5):810-5.
68. Rakita S, Bloomston M, Villadolid D, Thometz D, Zervos E, Rosemurgy A. Esophagotomy during laparoscopic Heller myotomy cannot be predicted by preoperative therapies and does not influence long-term outcome. J Gastrointest Surg. 2005 Feb;9(2):159-64.
69. Rosemurgy AS, Bloomston M, Clark WC, Thometz DP, Zervos EE. H-graft portacaval shunts versus TIPS: ten-year follow-up of a randomized trial with comparison to predicted survivals. Ann Surg. 2005 Feb;241(2):238-46
70. Zervos, EE, Osborne, DA, Boe, BA, Rosemurgy, AS. Mortality following shunting for complicated portal hypertension is dependant upon hospital volume for surgical but not radiological procedures: review of a statewide database. J GI Surg (submitted).
71. Bloomston M, Shafii A, Zervos E, Rosemurgy AS, TIMP-1 antisense gene transfection attenuates the invasive potential of pancreatic cancer cells in vitro and inhibits tumor growth in vivo. Am J Surg. 2005 Jun;189(6):675-9.
72. D'Alessio MJ, Rakita S, Bloomston M, Chambers CM, Zervos EE, Goldin SB, Poklepovic J, Boyce HW, Rosemurgy AS. Esophagography predicts favorable outcomes after laparoscopic Nissen fundoplication for patients with esophageal dysmotility. J Am Coll Surg. 2005 Sep;201(3):335-42.
73. Korkolis, DP, Osborne, D., Boe, BA, Al-Saif, O., Gonzalvo, A., Carey, LC, Rosemurgy, AS, Zervos, EE. Lymphoepithelial cyst of the pancreas in a young woman. Surg Rounds 29(1); 2006:21-25.
74. Zervos, EE, Tanner, SM, Osborne, DA, Bloomston PM, Rosemurgy, AS, Ellison, EC, Melvin, WS., delaChapelle, A. Differential gene expression in patients genetically predisposed to pancreatic cancer. J Surg Res. 2006 Oct;135(2):317-22. Epub 2006 Jun 30.
75. Durkin, AJ, Osborne, D, Yeatman, TJ, Rosemurgy AS, Armstrong, C., Attkisson, L., Zervos, EE. EGF receptor antagonism inhibits cellular growth and provides a survival benefit in a murine model of pancreatic adenocarcinoma. J Surg Res 2006 Sep; 135(1): 195-201. Epub 2006 May 6.
76. Osborne DA, Zervos EE, Strosberg J, Boe BA, Malafa M, Rosemurgy AS, Yeatman TJ, Carey L, Duhaine L, Kvols LK. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Ann Surg Oncol. 2006 Apr;13(4):572-81. Epub 2006 Feb 28.
77. Durkin, AJ, P. Bloomston, PM, Giarelli, NB, Rosemurgy , AS, Zervos, EE. Intraoperative Portal Vein Color Flow Doppler Predicts Outcome Following Small Diameter Prosthetic H-graft Portacaval Shunt, Int J Ultrasonography (submitted).
78. Rosemurgy AS, Osborne D, Zervos EE. Portal hypertension: the role of shunting procedures.Adv Surg. 2005;39:315-29.
79. Zervos, EE, Alexander, G., Osborne, D., Rosemurgy, AS. Participation in Experimental Protocols for Pancreatic Cancer Confers No Survival Disadvantage Regardless of Therapeutic Strategy Employed. Ann Surg Onc (submitted).
80. Osborne D, Pappas E, Alexander G, Boe B, Cantor AB, Rosemurgy AS, Zervos EE. A complication free course ensures a survival advantage in patients after regional therapy for metastatic colorectal cancer. Am Surg. 2006 Jun;72(6):505-510.
81. S. Cowgill, S. Al-Saadi, D. Villadolid, E. Zervos, A. Rosemurgy II. Does Barrett's esophagus impact outcome after laparoscopic Nissen fundoplication? Am J Surg. 2006 Nov;192(5):622-6.
82. Cowgill, E. Carey, D. Villadolid, S. Al-Saadi, E. Zervos, A. Rosemurgy Preshunt liver function remains the prominent determinant of survival after portasystemic shunting. The American Journal of Surgery, Volume 192, Issue 5, Pages 617-621 S.
83. Osborne DA, Alexander G, Boe B, Zervos EE. Laparoscopic cholecystectomy: past, present, and future.Surg Technol Int. 2006;15:81-5.
84. Cowgill SM, Thometz D, Clark W, Villadolid D, Carey E, Pinkas D, Zervos E, Rosemurgy A 2nd. Conventional Predictors of Survival Poorly Predict and Significantly Underpredict Survival after H-graft Portacaval Shunts. J Gastrointest Surg. 2007 Jan;11(1):89-94.
85. Rosemurgy AS, Molloy DL, Thometz DP, Villadolid DV, Cowgill SM, Zervos EE. TIPS in Florida: is its application a result of evidence-based medicine? J Am Coll Surg. 2007 May;204(5):794-801; discussion 801-2. Epub 2007 Mar 26. PMID: 17481486 [PubMed - in process]
86. Rosemurgy A, Thometz D, Clark W, Villadolid D, Carey E, Pinkas D, Rakita S, Zervos E.Survival and Variceal Rehemorrhage After Shunting Support Small-Diameter Prosthetic H-graft Portacaval Shunt.J Gastrointest Surg. 2007 Mar;11(3):325-32.
87. D'Alessio ML, Thometz D, Boe BA, Villadolid DV, Zervos EE, Rosemurgy AS. Transduodenal Excision of Ampullary Polyp with Biliopancreatic Sphincteroplasty. Ann Surg Oncol 2007 Jun 27;
88. Goldin SB, Bradner MW, Zervos EE, Rosemurgy AS 2nd. Assessment of pancreatic neoplasms: review of biopsy techniques.J Gastrointest Surg. 2007 Jun;11(6):783-90.
89. Rosemurgy AS, Molloy DL, Thometz DP, Villadolid DV, Cowgill SM, Zervos EE. TIPS in Florida: is its application a result of evidence-based medicine?J Am Coll Surg. 2007 May;204(5):794-801; discussion 801-2. Epub 2007 Mar 26.
Published Motion Pictures
1. D'Alessio ML, Thometz D, Boe BA, Villadolid DV, Zervos EE, Rosemurgy AS. Transduodenal Excision of Ampullary Polyp with Biliopancreatic Sphincteroplasty.Ann Surg Oncol. 2007 Jun 27;
Presentations:
1. Victor Vaughn Medical Historical Society, Ann Arbor, MI February 2, 1992.
Title: The University of Michigan Old Main Hospital: A Cultural Icon for Nearly Seven Decades.
2. University of Michigan AOA Induction Ceremony Keynote Address, Ann Arbor, MI April 1992.
Title: The University of Michigan Old Main Hospital: A Cultural Icon for Nearly Seven Decades
3. American College of Surgeons Florida Committee on Trauma, St. Petersburg, FL, July, 1994.
Title: Oral vs. Parenteral Administration of Fluconazole in Critically Ill Trauma Patients: A Study Comparing Routes of Administration.
4. American College of Surgeons, Region IV Resident Paper Competition, Nasheville, TN November, 1994.
Title: Oral vs. Parenteral Administration of Fluconazole in Critically Ill Trauma Patients: A Study Comparing Routes of Administration.
5. Florida Surgical Society, Tampa, FL, August 18-20, 1995.
Title: Fluconazole Increases the Bactericidal Activity of Neutrophils.
6. American College of Surgeons Florida Committee on Trauma, Orlando, FL, July, 1995.
Title: Fluconazole Increases the Bactericidal Activity of Neutrophils.
7. Ninth Annual Meeting of the Eastern Association for the Surgery of Trauma, Orlando, FL January 10-13, 1996.
Title: Fluconazole Increases the Bactericidal Activity of Neutrophils.
8. Annual Meeting of the Southeastern Surgical Society, Tampa, FL, February 2-5, 1996.
Title: Peritoneovenous Shunts in Patients with Intractable Ascites: Palliation at What Price?
9. Twenty Sixth Annual Meeting of the Western Association for the Surgery of Trauma, Grand Targhee, WY, February 25 - March 2, 1996.
Title: Fluconazole Increases the Bactericidal Activity of Neutrophils through Non-Cytokine Mediated Pathway.
10. Eleventh Annual SSAT/Ross Residents and Fellows Research Conference, Napa Valley, CA, May 17-18, 1996.
Title: Matrix Metalloproteinase Blockade Decreases Mortality in an Orthotopic Model of Human Pancreatic Cancer.
11. Annual Meeting of the American Gastroenterological Association, San Francisco, CA, May 19-22, 1996.
Title: A Prospective, Randomized Trial Comparing TIPS vs. Peritoneovenous Shunts in the Management of Intractable Ascites
Title: Elevated Protein Kinase C- Expression is Associated with an Increased Neoplastic Phenotype in Human Pancreatic Cancer Cells.
13. Thirty-seventh Annual Meeting of the Society for Surgery of the Alimentary Tract, San Francisco, CA, May 19-22, 1996.
Title: Matrix Metalloproteinase Blockade Decreases Mortality in an Orthotopic Model of Human Pancreatic Cancer.
14. American Society for Bariatric Surgery, Quebec City, Quebec, Canada, June 12, 1996.
Title: Does Adequate Weight Loss Following Bariatric Surgery Predict Staple Line Failure? A Prospective Study.
Title: Impact of Bariatric Surgery on Body Image Perception and Sexuality in Morbidly Obese Patients and Their Partners.
16. University of South Florida Surgical Alumni Society, Tampa, FL June 18, 1996.
Title: Matrix Metalloproteinase Blockade Decreases Mortality in an Orthotopic Model of Human Pancreatic Cancer.
17. Florida Surgical Society, Captiva Island, FL, August 15-18, 1996.
Title: Matrix Metalloproteinase Inhibition Attenuates Human Pancreatic Cancer Growth In-vitro and Decreases Mortality and Tumorigenesis In-vivo.
18. Forty Ninth Annual Meeting Frederick A. Coller Surgical Society, Colorado Springs, CO, October 2-4, 1996
Title: Matrix Metalloproteinase Inhibition Attenuates Human Pancreatic Cancer Growth In-vitro and Decreases Mortality and Tumorigenesis In-vivo.
19. USF Division of Trauma CME Conference, Tampa, FL, October 18, 1996.
Title: Trauma Research Protocols: Conception, Design and Execution
20. University of South Florida Department of Surgery Grand Rounds, Tampa, FL, October 19, 1996.
Title: Systemic Mediators of Hemorrhagic Shock.
21. Annual Meeting of the Society of Abdominal Surgeons, Tampa, FL November 2-4, 1996.
Title: Novel Therapeutic Strategies in the Treatment of Pancreatic Cancer
Title: Management of the Intractable Ascites in the Cirrhotic Patient
23. Annual Meeting of the American Pancreatic Association, Chicago, IL November, 1996.
Title: Reduced Tumorigenicity of Pancreatic Cancer with Matrix Metalloproteinase Inhibition.
Title: Inhibition of post transcription cytokine gene processing proximal in the cytokine cascade minimizes the severity of acute pancreatitis.
25. American College of Surgeons Florida Committee on Trauma, Orlando, FL, November 9, 1996.
Title: Sublethal Hemorrhage Induces Tolerance to Endotoxic Death.
Title: Do Anabolic Steroids Improve Outcome In Trauma Patients?: A Placebo Controlled, Prospective, Randomied Trial
27. Annual Meeting of the Association for Academic Surgery, Chicago, IL, November, 1996.
Title: Matrix Metalloproteinase Inhibition Attenuates Human Pancreatic Cancer Growth In-vitro and Decreases Mortality and Tumorigenesis In-vivo.
28. American College of Surgeons, Region IV Resident Paper Competition, Louisville, KY, November 30, 1996.
Title: Sublethal Hemorrhage Induces Tolerance to Endotoxic Death.
29. One Hundred Eighth Annual Meeting of the Southern Surgical Association, Palm Beach FL, December 2-5, 1996.
Title: Differential Effects on Effective Hepatic Blood Flow: A Comparison Between TIPS and Small Diameter H-Graft Portacaval Shunt.
30. Eastern Association for the Surgery of Trauma, Sanibel Island, FL, January 18, 1997.
Title: Bioavailability of Fluconazole in Burn Patients: A Study Comparing Routes of Administration.
31. Southeastern Surgical Congress, Nashville, TN, February 5, 1997.
Title: Small Diameter H-Graft Portacaval Shunt Reduced Portal Flow Yet Maintains Effective Hepatic blood Flow.
32. Fifty Eighth Annual Meeting of the Society of University Surgeons, Tampa, FL, February 13, 1997.
Title: Matrix Metalloproteinase Inhibitors in the Treatment of Pancreatic Cancer.
33. Society of University Surgeons Residents Conference, Tampa, FL, February 15, 1997.
Title: Modulation of the Cytokine Response to Sepsis through Sub-lethal hemorrhage is Neither Cytokine Nor Model Specific.
Title: PKC- antisense oligodeoxynucleotide treatment confers a survival benefit in an orthotopic model of pancreatic cancer.
Title: Do Anabolic Steroids Improve Outcome In Trauma Patients?: A Placebo Controlled, Prospective, Randomied Trial
36. University of South Florida Health Science Center Annual Research Symposium, February 15, 1997.
Title: Conditioning to Hemorrhagic Shock Improves Survival in a Rat Model.
37. Twenty Seventh Annual Meeting of the Western Association for the Surgery of Trauma, Snowbird, UT, March 3, 1997.
Title: Modulation of the Cytokine Response to Sepsis through Sub-lethal hemorrhage is Neither Cytokine Nor Model Specific.
38. Fifty-third annual Central Surgical Association Annual Meeting, Chicago IL March 7-9, 1997.
Title: TIPS vs. H-Graft Portacaval Shunt in the Management of Bleeding Varices: A Cost-Benefit Analysis
39. American Association for Cancer Research, Annual Meeting, San Diego, CA, April 11-14, 1997.
Title: PKC- antisense oligodeoxynucleotide treatment confers a survival benefit in an orthotopic model of pancreatic cancer.
40. 17 th Annual Meeting of the Surgical Infection Society, Pittsburgh, PA, May 1-3, 1997.
Title: Cytokine activation through sub-lethal hemorrhage is protective against early lethal endotoxic challenge.
41. 17 th Annual Meeting of the Surgical Infection Society, Pittsburgh, PA, May 1-3, 1997.
Title: Pancreatic ascites as a powerful inducer of inflammatory cytokines: the role of known vs unknown factors.
42. 21st Annual Meeting of the Association of VA Surgeons, Louisville, KY, May 5-7, 1997.
Title: Immediate and long-term portal hemodynamic consequences of small diameter h-graft portacaval shunt.
43. American Gastroenterological Association, Digestive Disease Week 1997, Washington, D.C. May 15-21 1997.
Title: Endovascular salvage of the failing TIPS patient.
44. Society for Surgery of the Alimentary Tract, Digestive Disease Week , Washington, D.C. , May 15-21, 1997
Title: Small diameter H-graft portacaval shunt for bleeding esophageal varices: excellent results in over 110 patients.
Title: Pancreatitis confers a survival benefit in an orthotopic model of pancreatic cancer.
46. 31st Annual Meeting of the Pancreas Club, Inc., Bethesda, MD, May 11, 1997
Title: Inhibition of PKC- through specific antisense therapy confers a survival benefit in an orthotopic pancreatic cancer model.
47. 14th Annual Meeting of the American Society for Bariatric Surgery, Chicago, IL June 5-7, 1997
Title: Vertical banded gastroplasty in a patient with multiple personalities: Nuances and complexities of care.
Title: Outcome following bariatric surgery in super vs. morbidly obese patients: does weight matter?
49. Fifty Seventh Annual Meeting of the American Association for the Surgery of Trauma, Waikoloa, Hawaii, Sept. 23-28, 1997
Title: Conditioning to Hemorrhagic Shock Improves Survival in a Rat Model
50. 101st Annual Meeting of the Frederick C. Coller Surgical Society, Lake of the Ozarks, MO, October 9-12, 1997
Title: Achieving Tolerance to Hemorrhagic Shock in Rats through Repeat Serial , sublethal Hemorrhage
51. 83rd Annual Clinical Congress, American College of Surgeons, Surgical Forum, Chicago, IL Oct. 12-16, 1997
Title: Conditioning to hemorrhagic shock improves survival and attenuates inflammatory cytokine gene induction in the lung, liver and spleen of rats
52. 91st Annual Scientific Assembly, Southern Medical Association, Charlotte, NC, November 6-8, 1997
Title: Further Application of Advanced Laparoscopy in the 90's: An alternative for failed anti-reflux surgery
53. 22nd Annual Hepatobiliary/Pancreatic Surgery Symposium, Tampa, FL November 9, 1997
Title: Cirrhosis and its complications: a surgeon’s perspective
54. University of South Florida Department of Surgery Grand Rounds, December 19, 1997
Title: Renal vein thrombosis in a transplanted kidney: presentation, diagnosis and management.
55. Twenty Eighth Annual Meeting of the Western Trauma Association, February 21-26, 1998, Lake Louise, Alberta, Canada
Title: Do anabolic steroids improve outcome in trauma patients? A prospective, randomized trial.
56. Annual Meeting of the Southeastern Surgical Congress, Atlanta, GA, February 2-4, 1998.
Title: Quality of life and anti-reflux medication use following laparoscopic Nissen fundoplication
57. Annual Meeting of the Society of University Surgeons, Milwaukee, WI, February, 1998.
Title: Directed antisense therapy confirms the role of pkc-alpha in the tumorigenicity of pancreatic cancer
58. 22nd Annual Meeting of the Association of VA Surgeons, Baltimore, MD, April 26-28, 1998
Title: Matrix metalloproteinase inhibition selectively decreases MMP-2 activity in a murine model of pancreatic cancer
59. 32nd Annual Meeting of the Pancreas Club, Inc. New Orleans, LA, May 19, 1998
Title: Matrix metalloproteinases in pancreatic cancer: effects of differentiation on activity in vitro and in vivo.
60. Annual Meeting of the American Gastroenterological Association, New Orleans, LA, May 21, 1998
Title: Matrix metalloproteinases in pancreatic cancer: effects of differentiation on activity in vitro and in vivo.
61. 44 th Clinical Meeting of the Frederick A. Coller Surgical Society, Williamsburg, VA Oct. 1-4, 1998
Title: Metalloproteinase inhibition in pancreatic cancer reduces both production and activity of MMP-2.
62. Annual Meeting of the Association for Academic Surgery, Seattle, WA, Nov.22, 1998
Title: Matrix metalloproteinase inhibition supresse MMP-2 activity and activation of PANC-1 cells in vitro.
63. Annual Meeting of the Pancreas Club Inc., Orlando, FL May, 1999.
Title: Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prologs survival in a murine model of human pancreatic cancer.
64. Annual Meeting of the Association for Academic Surgery, Philadelphia, PA November 20, 1999.
Title: Overexpression of TIMP-1 in human pancreatic cancer cells reduces in vitro invasion and reduces in vivo tumor growth.
65. Annual Meeting of the Society of Surgical Oncology, New Orleans, LA, March 1999.
Title: Localizing the sentinel node outside the specialty center, success of the lymphatic mapping course in disseminating new technology.
66. American Liver Foundation Gulf Coast Chapter: Latest strategies and management of liver disease 2000.
Title: Management of intractable ascites
67. Society of Surgical Oncology, 53rd Annual Cancer Symposium, New Orleans, LA March 16-19, 2000.
Title: Localizing the senitinel node outside of the specialty center: success of the lymphatic mapping course in disseminating new technology.
68. 47th Annual Meeting of the Society of Nuclear Medicine, St. Louis, MO June 3-7,2000
Title: Localization of recurrent colorectal cancer using FDG: correlation between PET and intraoperative beta and gamma probe
69. 34th Annual Meeting of the Association for Academic Surgery, Tampa, FL, November 2-4, 2000.
Title: FDG-Pet Guided Surgery for Recurrent Colorectal Cancer: A Feasibility Study
70. University of South Florida College of Medicine Department of Surgery Grand Rounds, Nov. 3, 2000.
Title: Bulls and Buckeyes: Sentinel Contributions to Radio Guided Surgery
71. 23rd Annual San Antonio Breast Cancer Symposium, San Antonio, Texas. December 6-9, 2000.
Title: Physiologic and Socioeconomic Consequences of Breast Cancer Surgery: A comparison between sentinel lymphadenectomy and axillary dissection
Title: Predictive value of the sentinel lymph node in breast cancer: how many sentinel nodes are enough?
72. Central Surgical Association, Tucson Arizona March 2001
Title: FDG-PET as an adjunct to CEA in the management of patients with presumed recurrent colorectal cancer and normal radiologic workup.
73. American Society of Breast Surgeons, Second annual meeting, La Jolla, CA May 4-6, 2001
Title: Selective sentinel lymph node analysis: potential for resource savings.
74. Cleveland Clinic Foundation, Minimally Invasive Approaches in Breast Cancer, June 8, 2001.
Invited guest speaker
Title: Technical Aspects of Lymphatic Mapping in Breast Cancer
75. Annual Clinical Congress of the American College of Surgeons, New Orleans, LA October 2001 – Post Graduate Course #10
Title: Management of Medically Refractory Ascites
76. 55th Annual Cancer Symposium – Society of Surgical Oncology – Denver, CO March 14-17, 2002
Title: Optimization
